Aviva Industries Limited Allots 32.40 Lakh Equity Warrants Worth ₹90.72 Crores on Preferential Basis

2 min read     Updated on 08 Jan 2026, 05:38 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Aviva Industries Limited has allotted 32,40,000 fully convertible equity warrants worth ₹90.72 crores to two non-promoter investors at ₹28.00 per warrant on January 08, 2026. The warrants, issued following AGM approval and BSE clearance, are convertible into equity shares within 18 months, with each allottee receiving 16,20,000 warrants representing 6.22% post-conversion shareholding.

29419694

*this image is generated using AI for illustrative purposes only.

Aviva Industries Limited has completed the allotment of 32,40,000 fully convertible equity warrants on a preferential basis to two non-promoter investors on January 08, 2026. The board of directors approved this allotment during their meeting held at the company's registered office, generating a total consideration of ₹90.72 crores.

Warrant Allotment Details

The warrants were issued at ₹28.00 per warrant, which includes a premium of ₹18.00 per warrant. The allotment was made in the first tranche following the special resolution passed by members during the Annual General Meeting on September 30, 2025, and the in-principle approval granted by BSE on January 02, 2026.

Parameter: Details
Total Warrants Allotted: 32,40,000
Issue Price: ₹28.00 per warrant
Premium: ₹18.00 per warrant
Total Consideration: ₹90.72 crores
Allotment Date: January 08, 2026

Allottee Information

The warrants have been allocated equally between two non-promoter category investors:

Allottee Name: Category Warrants Allocated Post-Issue Shareholding*
Parmar Alkeshbhai Ratanbhai Non-Promoter 16,20,000 6.22%
Solanki Arjunsinh Gambhirsainh Non-Promoter 16,20,000 6.22%

*Post-issue shareholding calculated assuming full exercise of warrants and consequent allotment of equity shares.

Conversion Terms and Compliance

Each warrant is convertible into an equivalent number of fully paid-up equity shares with a face value of ₹10.00 each. The warrant holders have a maximum period of 18 months from the allotment date to exercise their conversion option. The company has received 25% of the consideration amount upfront from the proposed allottees, as required under SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.

The remaining 75% of the consideration amount will be payable by the allottees upon exercising their conversion option. The allotment was conducted in accordance with Chapter V of SEBI (ICDR) Regulation 2018 and the Companies Act, 2013. Since warrants have been allotted rather than equity shares, there is currently no change in the company's paid-up share capital.

Regulatory Framework

The allotment process was completed following all necessary regulatory approvals and compliance requirements. The board meeting commenced at 4:30 PM and concluded at 5:00 PM on January 08, 2026. The number of equity shares to be allotted upon warrant exercise will be subject to appropriate adjustments as permitted under applicable rules, regulations, and laws.

like18
dislike

Aviva Industries Limited Allots 1.12 Crore Warrants Worth ₹31.32 Crores on Preferential Basis

2 min read     Updated on 07 Jan 2026, 07:19 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Aviva Industries Limited successfully allotted 1,11,85,000 fully convertible equity warrants worth ₹31.32 crores to seven non-promoter investors on January 07, 2026, at ₹28.00 per warrant including ₹18.00 premium. The preferential allotment followed shareholder approval in September 2025 AGM and BSE's in-principle approval on January 02, 2026. Warrants are convertible into equity shares within 18 months, with 25% consideration received upfront as per SEBI regulations.

29339357

*this image is generated using AI for illustrative purposes only.

Aviva Industries Limited has completed the allotment of 1,11,85,000 fully convertible equity warrants to seven non-promoter investors on January 07, 2026, raising ₹31.32 crores through preferential allotment. The board meeting held on January 07, 2026, approved the warrant allotment at an issue price of ₹28.00 per warrant, including a premium of ₹18.00 per warrant.

Warrant Allotment Details

The company allotted warrants to seven non-promoter category investors in the first tranche of the preferential issue. The allotment was conducted pursuant to a special resolution passed by members in the Annual General Meeting on September 30, 2025, and following BSE's in-principle approval granted on January 02, 2026.

Allottee Name Category Warrants Allotted Post-Issue Shareholding*
Hinhor Mahesh Madubhai Non-Promoter 16,10,000 7.06%
Pravinbhai Kashyabhai Jogari Non-Promoter 15,95,000 7.00%
Khalifa Irfan Yusufmiya Non-Promoter 15,85,000 6.95%
Chavdhari Navinbhai Rameshbhai Non-Promoter 15,95,000 7.00%
Anandbhai Jankabhai Gavli Non-Promoter 16,00,000 7.01%
Md Zahid Non-Promoter 16,10,000 7.06%
Thakor Jitendrasinh Jashvantsinh Non-Promoter 15,90,000 6.97%
Total 1,11,85,000

*Post-issue shareholding calculated assuming full exercise of warrants and consequent allotment of equity shares.

Conversion Terms and Compliance

Each fully convertible equity warrant can be converted into an equivalent number of fully paid-up equity shares with a face value of ₹10.00 each. The warrants carry a conversion period of 18 months from the allotment date, providing investors flexibility in timing their conversion decision.

Parameter Details
Issue Price ₹28.00 per warrant
Premium ₹18.00 per warrant
Face Value ₹10.00 per share
Conversion Period 18 months from allotment
Total Amount Raised ₹31.32 crores

The company has received 25% of the total consideration amount from the proposed allottees as required under SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The remaining 75% will be payable upon exercise of the conversion option by the warrant holders.

Regulatory Framework

The preferential allotment was conducted in accordance with Chapter V of SEBI (ICDR) Regulations 2018, read with the Companies Act, 2013. The board meeting commenced at 6:00 PM and concluded at 6:30 PM on January 07, 2026, at the company's registered office. As the company has allotted warrants rather than equity shares, there is currently no change in the paid-up share capital of the company.

The number of equity shares to be allotted upon warrant exercise will be subject to appropriate adjustments as permitted under applicable rules, regulations, and laws. The allotment represents the first tranche of the preferential issue approved by shareholders and regulatory authorities.

like20
dislike
More News on Aviva Industries Limited
Explore Other Articles